State Board of Administration of Florida Retirement System’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$536K Hold
15,847
﹤0.01% 1495
2025
Q4
$431K Hold
15,847
﹤0.01% 1601
2025
Q3
$636K Hold
15,847
﹤0.01% 1430
2025
Q2
$527K Hold
15,847
﹤0.01% 1500
2025
Q1
$464K Hold
15,847
﹤0.01% 1506
2024
Q4
$521K Hold
15,847
﹤0.01% 1511
2024
Q3
$704K Hold
15,847
﹤0.01% 1395
2024
Q2
$683K Sell
15,847
-2,170
-12% -$78.3K ﹤0.01% 1355
2024
Q1
$414K Buy
18,017
+2,170
+14% +$58.1K ﹤0.01% 1619
2023
Q4
$353K Hold
15,847
﹤0.01% 1789
2023
Q3
$392K Buy
15,847
+80
+0.5% +$2.12K ﹤0.01% 1681
2023
Q2
$447K Sell
15,767
-2,250
-12% -$56K ﹤0.01% 1637
2023
Q1
$414K Hold
18,017
﹤0.01% 1676
2022
Q4
$506K Sell
18,017
-7,660
-30% -$216K ﹤0.01% 1600
2022
Q3
$726K Hold
25,677
﹤0.01% 1377
2022
Q2
$569K Buy
25,677
+1,090
+4% +$24.6K ﹤0.01% 1575
2022
Q1
$716K Hold
24,587
﹤0.01% 1563
2021
Q4
$808K Hold
24,587
﹤0.01% 1555
2021
Q3
$1.14M Buy
24,587
+130
+0.5% +$6.28K ﹤0.01% 1351
2021
Q2
$1.35M Sell
24,457
-58,970
-71% -$3.3M ﹤0.01% 1275
2021
Q1
$4.31M Sell
83,427
-12,040
-13% -$596K 0.01% 913
2020
Q4
$4.14M Sell
95,467
-1,330
-1% -$52.6K 0.01% 907
2020
Q3
$3.39M Buy
96,797
+9,580
+11% +$420K 0.01% 895
2020
Q2
$4.66M Buy
87,217
+392
+0.5% +$18.2K 0.01% 804
2020
Q1
$3.08M Buy
86,825
+148
+0.2% +$6.84K 0.01% 819
2019
Q4
$4.14M Buy
86,677
+1,030
+1% +$38.9K 0.01% 862
2019
Q3
$2.77M Buy
85,647
+440
+0.5% +$18.2K 0.01% 936
2019
Q2
$4.25M Buy
85,207
+10,950
+15% +$585K 0.01% 860
2019
Q1
$5.01M Buy
74,257
+860
+1% +$50.1K 0.01% 802
2018
Q4
$3.38M Buy
73,397
+6,461
+10% +$399K 0.01% 869
2018
Q3
$5.16M Buy
66,936
+115
+0.2% +$9.25K 0.01% 826
2018
Q2
$5.63M Buy
66,821
+5,600
+9% +$488K 0.02% 800
2018
Q1
$5.01M Buy
61,221
+6,238
+11% +$482K 0.01% 798
2017
Q4
$3.14M Buy
54,983
+844
+2% +$53.1K 0.01% 941
2017
Q3
$3.61M Buy
54,139
+3,510
+7% +$211K 0.01% 897
2017
Q2
$2.6M Buy
50,629
+11,156
+28% +$570K 0.01% 977
2017
Q1
$2.31M Buy
39,473
+126
+0.3% +$6.04K 0.01% 1000
2016
Q4
$1.64M Buy
39,347
+3,419
+10% +$179K 0.01% 1161
2016
Q3
$1.9M Buy
35,928
+920
+3% +$40.1K 0.01% 1067
2016
Q2
$1.47M Buy
35,008
+9,154
+35% +$452K ﹤0.01% 1151
2016
Q1
$1.05M Buy
25,854
+3,182
+14% +$136K ﹤0.01% 1396
2015
Q4
$1.47M Buy
22,672
+1,624
+8% +$107K 0.01% 1224
2015
Q3
$1.49M Buy
21,048
+140
+0.7% +$13.7K 0.01% 1217
2015
Q2
$2.32M Buy
20,908
+10,346
+98% +$1.11M 0.01% 1064
2015
Q1
$996K Buy
10,562
+975
+10% +$109K ﹤0.01% 1556
2014
Q4
$1.07M Hold
9,587
﹤0.01% 1539
2014
Q3
$588K Hold
9,587
﹤0.01% 1876
2014
Q2
$439K Buy
+9,587
New +$391K ﹤0.01% 2096

Other funds holding AGIO

State Board of Administration of Florida Retirement System's AGIO Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System held its Agios Pharmaceuticals (AGIO) position steady in Q1 2026 at 15,847 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

State Board of Administration of Florida Retirement System first reported a position in AGIO in Q2 2014 and has held it in 48 quarters since. The position peaked at $5.63M in Q2 2018. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • State Board of Administration of Florida Retirement System held 15,847 shares of Agios Pharmaceuticals worth $536K as of Q1 2026.
  • State Board of Administration of Florida Retirement System left its Agios Pharmaceuticals share count unchanged in Q1 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1495 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Agios Pharmaceuticals in Q2 2014 and has held it in 48 quarters since.
  • State Board of Administration of Florida Retirement System's Agios Pharmaceuticals position peaked at $5.63M in Q2 2018.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.